ProtaGene CGT GmbH

ProtaGene is a specialized analytical partner supporting the development of cell and gene therapies with a strong focus on genomic safety assessment and molecular characterization. Building on more than 25 years of scientific expertise in vector integration analysis, the company provides comprehensive services including integration site analysis (ISA), vector copy number (VCN) determination, biodistribution studies, replication competent virus testing, and advanced bioinformatics. ProtaGene leverages tailored sequencing and bioinformatics approaches to enable high resolution characterization of vector batch characterization, vector integration events, vector persistence, and genomic safety profiles.The company has played a pioneering role in the field of gene therapy safety assessment and supports developers from preclinical research through clinical development and post marketing studies. With deep scientific expertise, robust quality systems, and a proven track record in regulatory submissions, ProtaGene helps sponsors generate the critical data needed to evaluate product safety, understand vector biology, and advance innovative therapies toward patients worldwide.